New combo approach for breast cancer: reconstruction and radiation together
NCT ID NCT03627988
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 study looked at women with invasive breast cancer who had a mastectomy with immediate prosthetic breast reconstruction, followed by TomoTherapy (a type of radiation) with or without chemotherapy. The goal was to see how often the reconstruction was successful. 66 patients were followed for up to 3 years. The study measured success rates, treatment quality, and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mastectomy with immediate prosthetic breast reconstruction and TomoTherapy radiation
What this could lead to
If successful, this approach could offer a safe and effective way to combine breast reconstruction with radiation therapy after mastectomy, improving cosmetic outcomes without delaying cancer treatment.
What could go wrong
This is a small, non-randomized phase 2 study with only 66 participants, so results may not apply to everyone. Complications from surgery or radiation, such as infection or implant issues, are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonie
Bordeaux, France
-
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, 31059, France